Lotus Pharmaceutical Co., Ltd. announced the appointment of Valerie Lau as APAC Chief Commercial Officer, effective February 15, 2024. Valerie Lau is Cluster Vice President of Menarini Asia Pacific Pte. Ltd.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
323 TWD | -1.82% | +3.19% | +18.75% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.75% | 2.62B | |
+33.28% | 704B | |
+28.59% | 577B | |
-3.60% | 348B | |
+18.66% | 327B | |
+4.59% | 288B | |
+14.81% | 234B | |
+4.93% | 198B | |
-9.78% | 194B | |
-4.03% | 147B |
- Stock Market
- Equities
- 1795 Stock
- News Lotus Pharmaceutical Co., Ltd.
- Lotus Pharmaceutical Co., Ltd. Announces the Appointment of Valerie Lau as APAC Chief Commercial Officer, Effective February 15, 2024